Skip to main content
Premium Trial:

Request an Annual Quote

Amersham, Swiss Bioinformatics Firm GeneBio Launch Bioinformatics Partnership

NEW YORK, Jan. 8-Amersham Biosciences and Geneva Bioinformatics will partner to offer bioinformatics tools for proteomics research, the two companies said today.

 

Through the partnership, Amersham will become the exclusive distributor of GeneBio's Bioinformatics and Proteomics Training Program, which teaches researchers how best to use bioinformatics and data analysis tools.

 

Further details and financial specifics of the collaboration were not revealed.

 

GeneBio is a Swiss bioinformatics company that has partnerships with the Swiss Institute of Bioinformatics, the University Hospital of Geneva and the University of Geneva.

 

For more information, see the press release.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.